
RxSight's Chief Operating Officer, Ilya Goldshleger, sold company stock worth $14,205. The transaction details, including the date and reason for the sale, were not disclosed in the provided information.
This story was originally reported by Investing.com. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
Crowd-sourced evaluation based on verified reader feedback
No reader evaluations recorded yet โ be the first to rate the coverage tone above!
Quick Story Reactions:
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.